Bioasis Technologies Inc

(OTC: BIOAF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 203 533-7082
Address: 14 Water Street
Address 2: P.O. Box 64
State: CT
City / Town: Guilford
Country: US
Postal Code: 06437

Issuer Information

Exchange: OTCQB
CEO: Deborah Ann Rathjen
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A